[1]
N. Pardeshi, V. Satapara, and K. Patel, “Nitrosamine Contamination in Pharmaceuticals: Regulatory Perspectives and Control Strategies of USFDA, EMA & HC”, Int J Drug Reg Affairs, vol. 12, no. 1, pp. 1-8, Mar. 2024.